NDEV Launches Rx/Cannabis Online Platform, Accelerates Provider Enrollment

20K Prescription Drug Formulary Merges with Cannabis Benefits for a Unique Dual-Benefit Solution

MIAMI, FL  – Novus Acquisition and Development, Corp. (OTC: NDEV), d/b/a Novus Cannabis MedPlan ®., the first and only health insurance carrier that integrates cannabis into traditional health plans, today announced the completion and rollout of its Novus Prescription MedPlan. This massive milestone firmly establishes Novus as the singular, dominant force at the critical intersection of traditional healthcare through health insurance and the rapidly evolving cannabis medicine industry.

The newly completed

Novus Prescription MedPlan immediately launched with an initial formulary of 20,000 covered prescription drugs. This massive expansion of scope dramatically elevates the MedPlan's value proposition and market appeal, positioning Novus as the premier carrier providing both traditional prescription medication coverage and cannabis benefits to policyholders. Furthermore, it ensures the plans are Health Savings Account (HSA)-compatible. Positioning Novus strategically to attract high-value policyholders utilizing tax-deductible health savings.

Growth and Market Dominance

The rollout of the Novus Prescription MedPlan has triggered an immediate and dramatic acceleration in provider enrollment.

This is a pivotal moment, marking an inflection point for NDEV shareholders," said Frank Labrozzi, CEO of Novus Cannabis MedPlan. "We have engineered and deployed the market's first comprehensive dual-benefit package, effectively commanding the critical intersection of prescription drug plans and cannabis benefits. Our unique reimbursement model has triggered an explosive enrollment pace among cannabis companies, establishing a new, reliable revenue stream for our network partners and demonstrating a rapidly expanding, sustainable market share for Novus.

The Future of Healthcare: Novus Answers the National Call

The launch of the Novus Prescription MedPlan is critically timed, coinciding with the recent, high-profile national discussion around the role of cannabis in senior healthcare.

In late September 2025, President Donald Trump posted a video on Truth Social promoting the use of cannabidiol compounds that are beneficial for senior healthcare and discussing the human body's endocannabinoid system. This significant statement, which highlighted the potential of cannabis to revolutionize senior health, created a seismic shift in public perception and market sentiment toward cannabis integration in medicine.

A Practical Solution to this National Discussion.

By deploying the Novus Prescription MedPlan, Novus is doing more than just providing benefits—it is actively establishing the commercial distribution channel necessary for pharmaceutical companies to formalize and distribute cannabis-based medicine. The company's ever-expanding provider network and sophisticated distribution platform are now poised to become the essential channel for future, FDA-approved cannabinoid pharmaceuticals, providing a regulatory and distribution pathway that has not previously existed.

The company's pioneering model provides a crucial framework to integrate cannabis-based treatments into formal health plans, a necessary step that answers the call for affordable and accessible alternatives to costly or addictive pharmaceuticals.

About Novus Cannabis MedPlan

Novus Acquisition and Development Corp. (OTC: NDEV) is the only health insurance carrier providing traditional prescription medications and cannabis benefits through its online distribution platform. Novus created the first nationwide, supplemental plan to offer coverage for THC and/or CBD, now significantly enhanced by the added value of the major prescription drug formulary. Novus is dedicated to providing affordable, comprehensive access to wellness and medical cannabis insurance policies for both cannabis and non-cannabis users across the United States.

Further Research:

• Financial Filings: Click Here
• Quote: Click Here
• Investor's Page: Click Here 

Forward-Looking Statements

This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. Novus disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is a not statements of historical fact may be considered to be forward-looking statements. Written words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.

Investor Contact Information

Investor Website

855-228-7355 

Email: [email protected]